Update on the management of Crohn's disease. - sprookjes - yvandenbroek - TriplyDB

Update on the management of Crohn's disease.

Update on the management of Crohn's disease.

http://www.wikidata.org/entity/Q37906356

about

Personalized medicine using DNA biomarkers: a review A phase II study of laquinimod in Crohn's disease.Helicobacter pylori and Crohn's disease: a retrospective single-center study from China A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.Changes of the cytokine profile in inflammatory bowel diseases.Helicobacter pylori infection and inflammatory bowel disease: is there a link?Methotrexate: an old new drug in autoimmune disease.Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety.Circulating microRNAs in Inflammatory Bowel Diseases.Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review.

P2860

Q27022319-289FC3E7-E9C4-4EE4-9C90-994B53A4859E Q35891861-E747CDB2-1530-4CF9-8100-B0B249934DA6 Q37050515-E4A91B23-F32C-4485-B1D5-7F23727DD4D5 Q37678199-93E4092C-66F7-4AA4-87E9-6ADFE793700C Q38058782-A5133C5D-CF21-45ED-94F3-CE2A06345ABE Q38219027-F9F78212-EFC6-4A7D-86B0-F9130946DA96 Q38253237-5D5EE529-537C-4558-8D80-C8A842651E4D Q38364465-A1192B96-8C9F-406E-9FA0-78303038A5C0 Q38938480-0C5BD911-193A-4C8B-9C6F-2960F0FE0517 Q47267820-94AA0258-E572-45A7-9517-E544520A4318

P2860

Update on the management of Crohn's disease.

http://www.wikidata.org/entity/Q37906356

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Update on the management of Crohn's disease.

@en

Update on the management of Crohn's disease.

@nl

type

label

Update on the management of Crohn's disease.

@en

Update on the management of Crohn's disease.

@nl

prefLabel

Update on the management of Crohn's disease.

@en

Update on the management of Crohn's disease.

@nl

P1433

Q37906356-F9A597E0-B39C-43D5-96BF-EBB550942A9A

P1476

Q37906356-164B92BB-A47B-45E4-993B-A7CF55D5343A

P2093

Q37906356-4666117B-CA25-480C-9D61-A64748F7B56F

Q37906356-79FAB0BF-2B91-41F5-BD8B-C422099B30EC

Q37906356-BB2286A0-3409-4E64-B0C7-6FFCF502DE18

P2860

Q37906356-0185187A-FE98-4185-B5FD-889036BCA498

Q37906356-041A167E-3768-4293-89BE-DF943A90A583

Q37906356-045EB318-09FB-4F21-B337-9D5C6881E230

Q37906356-069ECFF4-9DC1-41CA-8881-C396C0702AA0

Q37906356-0F118EA9-948B-4546-BA78-0B56F2C179D9

Q37906356-1B112054-4CFE-492E-AEC8-EF31445F46E1

Q37906356-26594E16-0181-4C96-BF69-F249B82C7BAF

Q37906356-3413F8D8-8181-4ABC-A997-F96DC719EF47

Q37906356-34EBA8E2-5782-4DA8-8795-48257298A5C2

Q37906356-3BC6603B-6272-4152-920E-3C0839A17829

P2888

Q37906356-938189EA-D1F0-41DD-8AD4-54EE2F4F80BC

P304

Q37906356-AB671786-FCFA-4E72-B51A-18AB49735C49

P31

Q37906356-07BE4D30-F5A1-4810-9C9C-BBEBA1558056

P356

Q37906356-A22F8D08-1D5F-47C8-AD59-5BE0AFCC3720

P433

Q37906356-3DCD10BF-1010-4CD2-9656-F1FB5F8C36BA

P478

Q37906356-293E6912-98E1-4A4E-BBFD-19D51513EB21

P577

Q37906356-5A70DDB4-2555-4D89-8A4C-B40D14B371E5

P698

Q37906356-B633B7E5-5DCA-49F7-896C-6306BED3ED5C

P921

Q37906356-E182A9DC-574F-4C60-9633-9DB06B8C7AE1

P356

S11894-011-0220-X

P1433

Current gastroenterology reports

P1476

Update on the management of Crohn's disease.

@en

P2093

Anna M Buchner

http://www.w3.org/2001/XMLSchema#string

Gary R Lichtenstein

http://www.w3.org/2001/XMLSchema#string

Wojciech Blonski

http://www.w3.org/2001/XMLSchema#string

P2860

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease.

The use of budesonide in the treatment of active Crohn's disease is good clinical practice.

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

P2888

s11894-011-0220-x

P304

465-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11894-011-0220-X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21792543

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease